Back to mobile site

H.C. Wainwright Reiterates Buy Rating on RenovoRx Inc. (RNXT)

April 4, 2025 6:43 AM EDT Send to a Friend
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $3.00 price target on RenovoRx Inc. (NASDAQ: RNXT).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login